Board summary
Key figures
31,386
Registered population
54.4% aged 18–64
28.7%
Aged 65+
ICB 19.9% · England 17.9%
4.6%
Ethnic minority (non-White)
1.7% Asian · England 9.6%
2.6%
In IMD quintile 1
ICB 17.1% · England 21.0%
~749
Core20 residents (est.)
Resident basis; registered basis ~3,625 · see page 3
10,795
Hypertension register
+3.39% in 3 yrs · England +5.60%
474
SMI register
26.1% of Thanet's
1,656
COPD register
Reviews +4.71% in 3 yrs
Forecast to 2030
7,292
Hypertension patients, 2030
+-3,503 on today
73.7%
QRISK ≥20% on statins, 2030
+4.42pp over 3 yrs
7.0%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Heart failure reviews fell behind England.
Functional reviews fell 24.3% from 2023 to 2025 (England +8.7%), reaching 71.7% against England's 78.5%, which may reflect recall gaps.
Age-five MMR second-dose coverage gap.
Q1 2025/26 age-five MMR coverage is 95.8% for dose 1 versus 88.4% for dose 2, reaching a 15 pp gap at Birchington Medical Centre.
Asthma review coverage exceeds national benchmark.
Annual asthma reviews rose +8.9% (2023 to 2025) to 70.8%, above England's 65.7%, though a modelled 957 patients remain unreviewed.
Population, age and ethnicity
Patients aged 65+ make up 28.7% of the list alongside 33 catchment care homes
Patients aged 65+ make up 28.7% (9,010) of CARE KENT PCN's 31,386 registered list, well above Thanet (23.6%), NHS Kent and Medway ICB (19.9%) and England (17.9%). Working-age adults (18–64) represent 54.4% (17,076; Thanet 57.7%, ICB 59.5%, England 62.7%), and children aged 0–17 comprise 16.9% (5,300; Thanet 18.7%, ICB 20.7%, England 19.6%). Census estimates show 95.4% White residents (Thanet 93.0%, ICB 88.6%, England 81.1%), leaving a 4.6% ethnic minority share. Practice lists sum to 49,023, creating an unreconciled gap against the 31,386 PCN list base.
Age profile
65+: ICB 19.9%, England 17.9%
Ethnicity
Older people · falls rows are Thanet local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Thanet LA) | 1,889 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 85.2% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 59.0% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Thanet LA) | 988 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Thanet LA) | 25.4 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
PCN Core20 deprivation is 2.6% overall but reaches 19.8% at Birchington Medical Centre
CARE KENT PCN's Core20 cohort is 2.6%, below Thanet (36.8%), NHS Kent and Medway ICB (17.1%) and England (21.0%). Practice Core20 shares span a 19.8 pp range: Birchington Medical Centre records 19.8%, while Ash Surgery records 0.0%. Population bases diverge before targeting: associated LSOA estimates yield 749 Core20 residents, while practice registered shares average 7.4% and sum to 3,625 patients, led by 2,518 at Birchington Medical Centre. Concentrated deprivation at Birchington Medical Centre may indicate uneven demand, which address-level practice audits would test once resident and registered denominators are reconciled.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
474
SMI register
0.97% recorded prevalence
322
Learning disability register
0.66% recorded prevalence
33
Care homes, 1,017 beds
In the PCN catchment
10.3%
Provide unpaid care
Thanet, Census 2021
Learning disability prevalence is 0.7% (322 patients; Thanet 0.7%, ICB 0.6%, England 0.6%), and severe mental illness is 1.0% (474 patients; Thanet 1.2%, ICB 0.9%, England 1.0%). The PCN catchment holds 33 care homes with 1,017 beds. These recorded registers and catchment care home beds are consistent with clinical demand for annual reviews, which practice workload audits would test.
Severe mental illness: physical health checks
SMI blood pressure checks reached 84.7% (England 83.4%), but BMI recording was 81.9% (England 82.1%) and alcohol recording in psychosis was 76.1% (England 81.8%). Full health checks cannot be assumed across the register.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
10,795
Hypertension register
+3.39%
Register growth, 3 yrs
Thanet +2.67% · England +5.60%
−1.12pp
BP control, under 80
≤140/90 · +2.89pp aged 80+
−3,503
More patients by 2030
Forecast 7,292 (22.38%)
Hypertension case-finding and control
Hypertension register prevalence is 22.1% (10,795 patients), above Thanet (18.8%), NHS Kent and Medway ICB (16.2%) and England (15.2%). This crude rate is consistent with an older population (28.7% aged 65+) and implies a base of 48,846 rather than the 31,386 list. While blood pressure control at age 80+ reached 82.8% (England 81.2%), under-80 control fell 1.7% over 2023 to 2025 (England +3.2%) to 65.7% (England 67.8%). Heart failure reviews also fell 24.3% over 2023 to 2025 (England +8.7%) to 71.7% (England 78.5%). Falling under-80 blood pressure control and heart failure reviews may reflect recall gaps, which proactive clinical audits could test.
Lipids and statins
Statin therapy in diabetes with CVD is 80.4% (Thanet 81.7%, NHS Kent and Medway ICB 83.3%, England 84.4%). For patients with QRISK ≥ 20%, lipid-lowering coverage is 62.8% (England 63.6%). Lower secondary prevention coverage indicates a need to audit high-risk prescribing protocols across practices.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 66,269 | £1.70 | £1.90 | £1.86 | £112,657 |
| Cardiovascular (all), 2025 | 84,280 | £2.99 | £3.57 | £3.33 | £251,997 |
In 2026, the PCN prescribed 66,269 lipid-regulating items at £1.70 per item, below Thanet (£2.10), NHS Kent and Medway ICB (£1.90) and England (£1.86). Across these items, the PCN spent £10,603 less than at England's unit cost. Lower unit cost does not establish clinical efficiency, which formulary and dosage reviews could test.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+8.86%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+2.77%
Asthma prevalence, PCN 3-yr % change
COPD prevalence is 3.4% (England 1.9%, Thanet 3.2%) and asthma prevalence is 7.0% (England 6.6%). Annual review rates exceed England for COPD (80.7% vs 76.4%) and asthma (70.8% vs 65.7%), though a modelled 957 asthma patients lack a recorded review on a 3,273 register. Asthma prescribing among children aged 5–19 is 1,836 items per 1,000 (England 1,488; Thanet 2,012), while second-hand smoke recording is 75.1% (England 78.8%), which clinical audits could assess.
Cancer register and children's immunisation
Cancer register prevalence is 6.6% (3,230 patients), above England (3.8%) and Thanet (5.1%). In Q1 2025/26 childhood immunisation, age-five MMR dose 1 coverage reached 95.8%, but dose 2 was 88.4%—a 7.4 pp same-cohort difference that is 6.6 pp below the 95.0% target, reaching 15 pp at Birchington Medical Centre. Recall audits could test whether pre-school reminder workflows explain the second-dose gap.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.6%
Kent and Medway ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,630
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Kent and Medway ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 82.1% | 85.4% | 23% | 1,509 |
| Prostate | 54.4% | 53.2% | 37% | 1,435 |
| Lung | 29.4% | 33.8% | 21% | 1,109 |
| Bowel | 48.2% | 47.0% | 29% | 1,013 |
| Skin cancer | 87.5% | 87.8% | 23% | 562 |
In 2022, 55.6% of staged cancers in NHS Kent and Medway ICB (4,661 of 8,384) were diagnosed at stage 1 or 2 (England 55.3%), trailing the 75.0% national ambition. Known-stage completeness was 63.6% (8,384 of 13,189; England 67.0%). Across the ICB, reaching 75.0% would require 1,627 extra early-stage diagnoses annually. Early detection was 29.4% in lung (England 33.8%) and 48.2% in bowel (England 47.0%). At PCN level, cancer register growth was +5.8% (2023 to 2025), trailing England (+9.0%), with Minster Surgery at +1.4% and Ash Surgery at +3.3%. ICB staging describes the wider system, not PCN performance.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026 (provisional), East Kent Hospitals University NHS Foundation Trust met the 31-day cancer standard at 96.7% (standard 96.0%; NHS Kent and Medway Integrated Care Board 95.8%, England 92.5%). However, it trailed on 28-day faster diagnosis at 71.3% (standard 75.0%; ICB 76.8%, England 79.3%) and 62-day treatment at 70.0% (standard 85.0%; ICB 75.9%, England 71.2%). Medway NHS Foundation Trust reached 81.6% and Mid and South Essex NHS Foundation Trust 50.2% on 62-day waits. At East Kent Hospitals, 47.6% waited 6+ weeks for MRI (England 21.4%) and 37.4% for CT (England 9.9%).
| Pathways within standard (%) | East Kent | Mid and South Essex | Medway | Kent and Medway ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.28 | 67.45 | 77.77 | 76.78 | 79.32 |
| 31-day treatment (96%) | 96.67 | 81.88 | 99.62 | 95.84 | 92.50 |
| 62-day referral to treatment (85%) | 70.01 | 50.25 | 81.64 | 75.93 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Kent | Mid and South Essex | Medway | England |
|---|---|---|---|---|
| MRI | 47.58 | 23.35 | 0.68 | 21.40 |
| CT | 37.45 | 6.07 | 0.00 | 9.92 |
| Echocardiography | 14.17 | 65.05 | 36.62 | 28.48 |
| Colonoscopy | 9.58 | 64.09 | 1.88 | 30.83 |
| Gastroscopy | 22.16 | 59.76 | 3.32 | 29.02 |
| All 15 DM01 tests | 48.38 | 41.54 | 14.20 | 23.14 |
| Community services activity | Kent residents | Kent and Medway ICB |
|---|---|---|
| Care contacts | 210,170 | 254,055 |
| Referrals | 59,360 | 68,085 |
| Patients with a contact | 60,605 | 72,060 |
Community services (residents of Kent), Jun 2026 (provisional). In June 2026 (provisional), community health service activity for Thanet residents recorded 210,170 total contacts. Adults aged 65 and over accounted for 138,250 of these contacts, representing 65.8% of all borough community activity. These figures reflect borough resident contacts rather than PCN-specific delivery, consistent with substantial older-age use of local community care.
Practice variation and patient experience
Practice phone access spans 33.7 pp and overall experience varies by 21.7 pp
In 2025/26, QOF overall achievement ranged from 77.6% at Ash Surgery to 94.7% at Minster Surgery, against an England sum of 92.5%. Vaccination and immunisation achievement showed a 45.5 pp spread, from 21.7% at St Peter's Surgery to 67.2% at Ash Surgery. These variations may reflect differing practice recall systems, which administrative audits could test.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Westgate Surgery | 121 | 1.4 | 74.8% | 72.2% | 91.3% |
| Broadstairs | 108 | 5.3 | 81.5% | 62.0% | 80.2% |
| Minster Surgery | 111 | 2.3 | 59.4% | 64.8% | 76.6% |
| Ash Surgery | 108 | 0.0 | 49.8% | 69.2% | 73.0% |
| Birchington | 112 | 19.8 | 47.7% | 72.6% | 71.4% |
| St Peter's Surgery | 88 | 7.4 | 61.7% | 78.0% | 69.6% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Thirteen measures trailed England, with heart failure reviews falling 24.3% over three years
Between 2023 and 2025, 13 of 25 measures trailed England. Heart failure reviews fell 24.3% (Thanet +12.1%, NHS Kent and Medway ICB +8.5%, England +8.7%) to 71.7% (England 78.5%), while dementia prevalence fell 25.5% (England +6.0%) and learning disability fell 11.6% (England +5.4%). Conversely, asthma reviews rose 8.9% (England +4.4%) to 70.8%, and diabetes HbA1c control rose 7.9% (England +4.4%) to 59.0%. Severe mental illness blood pressure checks gained 5.3 pp (England +4.4 pp). Slower register growth and falling reviews may indicate delivery slippage or coding shifts; clinical audits would test this.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
Dementia register
Learning disability register
Stroke register
BP control, under 80
Asthma reviews
Diabetes HbA1c control
BMI record (SMI)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Thanet | Asset | PCN | Thanet |
|---|---|---|---|---|---|
| Care homes (catchment) | 33 (1,017 beds) | n/a | Schools (catchment) | 63 | n/a |
| Children's centres | 5 | 9 | Places of worship | 69 | 84 |
| Libraries | 5 | 6 | Day centres (VCS) | 9 | 14 |
| Children and young people (VCS) | 1 | 3 | Carers support groups (VCS) | 2 | 4 |
| Primary schools (LA maintained) | 18 | 16 | Primary academies | 4 | 14 |
| Special schools | 1 | 2 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Pre-school MMR second-dose recall
In Q1 2025/26, age-five MMR coverage had a 7.4 pp gap between dose 1 (95.8%) and dose 2 (88.4%, below the 95.0% target by 6.6 pp), reaching 15 pp at Birchington Medical Centre. Low cost, quick to run.
Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.
Policy anchor: 10 Year Health Plan, shift from sickness to prevention.
Option 2
Core20 denominator and access audit
Weighted practice Core20 is 7.4% (3,625 estimated patients, including 2,518 at Birchington Medical Centre at 19.8%) versus 2.6% at PCN level (749 residents; England 21.0%). For discussion: the PCN could reconcile registered addresses against IMD deciles 1 and 2 and review phone access and recall at the highest-share practices. Moderate effort to run.
Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.
Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.
Option 3
Structured asthma review and smoke recording
Although asthma reviews rose +8.9% (2023 to 2025) to 70.8% (England 65.7%, Thanet 58.7%), a modelled 957 of 3,273 registered patients lack a review. For discussion: practices could run a single asthma recall template that prompts second-hand smoke recording alongside inhaler prescribing checks. Low cost, quick to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Older adult capacity list reconciliation (p2) | Aged 65+ | Neighbourhood health framework · NHS vaccination strategy | PCN |
| Targeted Core20 list reconciliation (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check audit (p4) | SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
| Under-eighty blood pressure recall (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool MMR recall audit (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cancer register and referral audit (p7) | Cancer: QOF prevalence | Core20PLUS5, 75% stage 1–2 by 2028 | PCN |
| Practice telephony and triage review (p9) | GPPS good overall experience of the practice | 10YHP, hospital to community | Practice |
| Option 1 · Pre-school MMR second-dose recall (p12) | MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Option 2 · Core20 denominator and access audit (p12) | Core20 cohort (IMD quintile 1) · GPPS easy to contact the practice by phone | Core20PLUS5 · 10YHP equity test · 10YHP, hospital to community | PCN & Practice |
| Option 3 · Structured asthma review and smoke recording (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
